Abstract: An aqueous dispersion of an embodiment includes visible-light responsive photocatalytic composite microparticles containing tungsten oxide and zirconium oxide, and an aqueous dispersion medium in which the photocatalytic composite microparticles are dispersed. In the photocatalytic composite microparticles, a ratio of a mass of the zirconium oxide to a mass of the tungsten oxide is in a range of from 0.05% to 200%, and a D50 particle size in particle size distribution is in a range of from 20 nm to 10 ?m. The aqueous dispersion has pH in a range of from 1 to 9.

Abstract: In one embodiment, an antiviral material includes at least one microparticles selected from tungsten oxide microparticles and tungsten oxide composite microparticles. The microparticles have an inactivation effect R of 1 or more expressed by [R=log C?log A], when there is evaluated a virus titer by inoculating on a specimen to which the microparticles are adhered, at least one virus selected from a low pathogenic avian influenza virus (H9N2), a high pathogenic avian influenza virus (H5N1) and a swine influenza virus, and irradiating the specimen with visible light having a wavelength of 380 nm or more and illuminance of 6000 lx. for 24 hours.

Abstract: An aqueous dispersion of an embodiment includes visible-light responsive photocatalytic composite microparticles containing tungsten oxide and zirconium oxide, and an aqueous dispersion medium in which the photocatalytic composite microparticles are dispersed. In the photocatalytic composite microparticles, a ratio of a mass of the zirconium oxide to a mass of the tungsten oxide is in a range of from 0.05% to 200%, and a D50 particle size in particle size distribution is in a range of from 20 nm to 10 ?m. The aqueous dispersion has pH in a range of from 1 to 9.

Abstract: A cation adsorbent of an embodiment includes tungsten oxide particles having a BET specific surface area in a range of 0.82 m2/g or more and 820 m2/g or less. The cation adsorbent is added to a solution to be treated containing cations being recovery objects, and the cation adsorbent adsorbing the cations is precipitated. The generated precipitate is separated from the solution to recover the cations.

Abstract: An aqueous dispersion of an embodiment includes visible-light responsive photocatalytic composite microparticles containing tungsten oxide and zirconium oxide, and an aqueous dispersion medium in which the photocatalytic composite microparticles are dispersed. In the photocatalytic composite microparticles, a ratio of a mass of the zirconium oxide to a mass of the tungsten oxide is in a range of from 0.05% to 200%, and a D50 particle size in particle size distribution is in a range of from 20 nm to 10 ?m. The aqueous dispersion has pH in a range of from 1 to 9.

Abstract: According to one embodiment, a photocatalyst body satisfies at least one condition described below, (1) a ratio of an absorption intensity at a wave number of 3450 cm?1 to a peak intensity of an absorption at about 1037 cm?1 being 2.5 or less in an analysis of a surface of the body, (2) a ratio of a maximum peak intensity of an absorption in a wave number range of not less than 1500 cm?1 and not more than 1700 cm?1 to a peak intensity of an absorption at about 1037 cm?1 being 0.7 or less in the analysis and (3) the photocatalyst body having no absorption peak in a wave number range of not less than 5000 cm?1 and not more than 5400 cm?1 or a ratio of a maximum peak intensity of an absorption to an absorption intensity at 5250 cm?1 being 1.7 or less in the analysis.

Abstract: A cation adsorbent of an embodiment includes tungsten oxide particles having a BET specific surface area in a range of 0.82 m2/g or more and 820 m2/g or less. The cation adsorbent is added to a solution to be treated containing cations being recovery objects, and the cation adsorbent adsorbing the cations is precipitated. The generated precipitate is separated from the solution to recover the cations.

Abstract: A cation adsorbent of an embodiment includes tungsten oxide particles having a BET specific surface area in a range of 0.82 m2/g or more and 820 m2/g or less. The cation adsorbent is added to a solution to be treated containing cations being recovery objects, and the cation adsorbent adsorbing the cations is precipitated. The generated precipitate is separated from the solution to recover the cations.

Abstract: In one embodiment, an antiviral material includes at least one microparticles selected from tungsten oxide microparticles and tungsten oxide composite microparticles. The microparticles have an inactivation effect R of 1 or more expressed by [R=log C?log A], when there is evaluated a virus titer by inoculating on a specimen to which the microparticles are adhered, at least one virus selected from a low pathogenic avian influenza virus (H9N2), a high pathogenic avian influenza virus (H5N1) and a swine influenza virus, and irradiating the specimen with visible light having a wavelength of 380 nm or more and illuminance of 6000 lx. for 24 hours.

Abstract: An aqueous dispersion of an embodiment includes visible-light responsive photocatalytic composite microparticles containing tungsten oxide and zirconium oxide, and an aqueous dispersion medium in which the photocatalytic composite microparticles are dispersed. In the photocatalytic composite microparticles, a ratio of a mass of the zirconium oxide to a mass of the tungsten oxide is in a range of from 0.05% to 200%, and a D50 particle size in particle size distribution is in a range of from 20 nm to 10 ?m. The aqueous dispersion has pH in a range of from 1 to 9.

Abstract: A cation adsorbent of an embodiment includes tungsten oxide particles having a BET specific surface area in a range of 0.82 m2/g or more and 820 m2/g or less. The cation adsorbent is added to a solution to be treated containing cations being recovery objects, and the cation adsorbent adsorbing the catious is precipitated. The generated precipitate is separated from the solution to recover the cations.

Abstract: In one embodiment, an antiviral material includes at least one microparticles selected from tungsten oxide microparticles and tungsten oxide composite microparticles. The microparticles have an inactivation effect R of 1 or more expressed by [R=log C?log A], when there is evaluated a virus titer by inoculating on a specimen to which the microparticles are adhered, at least one virus selected from a low pathogenic avian influenza virus (H9N2), a high pathogenic avian influenza virus (H5N1) and a swine influenza virus, and irradiating the specimen with visible light having a wavelength of 380 nm or more and illuminance of 6000 1× for 24 hours.

Abstract: An electronic apparatus (1) includes a power receiver (2) and an electronic apparatus main body (3). The power receiver (2) includes a power receiving coil (11) having a spiral coil, a rectifier (12) and a secondary battery (13). The electronic apparatus main body (3) includes an electronic device (14) and a circuit board (15). A magnetic foil (16) is arranged in at least one position between the spiral coil (11) and one of the secondary battery (13), the rectifier (12), the electronic device (14) and the circuit board (15).

Abstract: In one embodiment, an antiviral material includes at least one microparticles selected from tungsten oxide microparticles and tungsten oxide composite microparticles. The microparticles have an inactivation effect R of 1 or more expressed by [R=logC?logA], when there is evaluated a virus titer by inoculating on a specimen to which the microparticles are adhered, at least one virus selected from a low pathogenic avian influenza virus (H9N2), a high pathogenic avian influenza virus (H5N1) and a swine influenza virus, and irradiating the specimen with visible light having a wavelength of 380 nm or more and illuminance of 6000 1× for 24 hours.

Abstract: An electronic apparatus (1) includes a power receiving device (2) and an electronic apparatus main body (3). The power receiving device (2) includes a power receiving coil (11) having a spiral coil, a rectifier (12), and a secondary battery (13). The electronic apparatus main body (3) includes an electronic device (14) and a circuit board (15). A magnetic foil (16) is arranged in at least one position between the spiral coil (11) and the secondary battery (13), the rectifier (12), the electronic device (14), or the circuit board (15). The magnetic foil (16) has a ?r?·t value expressed as the product of the real component ?r? of relative permeability and the plate thickness t of 30000 or larger.

Abstract: Disclosed is an electronic apparatus (1) comprising a power receiving device (2) and an electronic apparatus main body (3). The power receiving device (2) comprises a power receiving coil (11) having a spiral coil, a rectifier (12) and a secondary battery (13). The electronic apparatus main body (3) comprises an electronic device (14) and a circuit board (15). A magnetic foil (16) is arranged in at least one position between the spiral coil (11) and the secondary battery (13), the rectifier (12), the electronic device (14) or the circuit board (15). The magnetic foil (16) has a value expressed as the product of the saturation flux density MS and the thickness t, namely Ms·t, of not less than 15.

Abstract: There are provided a high hardness, high corrosion resistance and high wear resistance alloy, wherein the alloy is an aging heat treated Cr(chromium)-Al(aluminum)-Ni(nickel)-base alloy, the proportion of a mixed phase of (? phase+?? phase+? phase) precipitated at grain boundaries of ? phase grains in a metal structure in the cross section of the alloy is not less than 95% in terms of area ratio, and the intensity ratio as measured by X-ray diffractometry of the alloy is not less than 50% and not more than 200% in terms of I?(110)/[I?(200)+I??(004)]×100, and a component comprising this alloy, a material for an alloy which can form this alloy, and a process for producing this alloy. The present invention can provide a Cr—Al—Ni-base alloy possessing excellent corrosion resistance, hardness, wear resistance, releasability, fatigue strength, and planishing property in a molding face, a component comprising this alloy, a material for an alloy which can form this alloy, and a process for producing this alloy.

Abstract: According to one embodiment, a photocatalyst body satisfies at least one condition described below, (1) a ratio of an absorption intensity at a wave number of 3450 cm?1 to a peak intensity of an absorption at about 1037 cm?1 being 2.5 or less in an analysis of a surface of the body, (2) a ratio of a maximum peak intensity of an absorption in a wave number range of not less than 1500 cm?1 and not more than 1700 cm?1 to a peak intensity of an absorption at about 1037 cm?1 being 0.7 or less in the analysis and (3) the photocatalyst body having no absorption peak in a wave number range of not less than 5000 cm?1 and not more than 5400 cm?1 or a ratio of a maximum peak intensity of an absorption to an absorption intensity at 5250 cm?1 being 1.7 or less in the analysis.

Abstract: There are provided a high hardness, high corrosion resistance and high wear resistance alloy, wherein the alloy is an aging heat treated Cr(chromium)-Al(aluminum)-Ni(nickel)-base alloy, the proportion of a mixed phase of (? phase+?? phase+? phase) precipitated at grain boundaries of ? phase grains in a metal structure in the cross section of the alloy is not less than 95% in terms of area ratio, and the intensity ratio as measured by X-ray diffractometry of the alloy is not less than 50% and not more than 200% in terms of I?(110)/[I?(200)+I??(004)]×100, and a component comprising this alloy, a material for an alloy which can form this alloy, and a process for producing this alloy. The present invention can provide a Cr—Al—Ni-base alloy possessing excellent corrosion resistance, hardness, wear resistance, releasability, fatigue strength, and planishing property in a molding face, a component comprising this alloy, a material for an alloy which can form this alloy, and a process for producing this alloy.

Abstract: In a scanning probe apparatus capable of always effectively canceling an inertial force to suppress vibration even in repetitive use while replacing a sample holding table or a probe, a stage for a sample or the probe includes a drive element for moving the sample holding table and movable portions movable in a direction in which an inertial force generated during movement of the sample holding table. The stage is configured so that the drive element, the movable portions, and the sample holding table or the probe are integrally detachably mountable to a main assembly of the scanning probe apparatus.